LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 15.58 | 27.76 | 8 | 685 | 0.0117 | -0.2358 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 15.58 | 27.76 | 921 | 685 | 1.3434 | 1.1318 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 17.28 | 27.76 | 3 | 838 | 0.0036 | -0.3640 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 17.28 | 27.76 | 740 | 838 | 0.8823 | 0.9497 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 17.28 | 27.76 | 9 | 838 | 0.0107 | -0.2047 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 17.28 | 27.76 | 1026 | 838 | 1.2233 | 1.0837 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 18.98 | 27.76 | 4 | 941 | 0.0043 | -0.3169 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 18.98 | 27.76 | 757 | 941 | 0.8043 | 0.9161 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 18.98 | 27.76 | 8 | 941 | 0.0085 | -0.2171 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 18.98 | 27.76 | 973 | 941 | 1.0338 | 1.0131 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 20.68 | 27.76 | 6 | 1119 | 0.0054 | -0.2497 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 20.68 | 27.76 | 791 | 1119 | 0.7069 | 0.8741 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 20.68 | 27.76 | 12 | 1119 | 0.0107 | -0.1455 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 20.68 | 27.76 | 981 | 1119 | 0.8767 | 0.9513 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 22.39 | 27.76 | 7 | 1305 | 0.0054 | -0.2196 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 22.39 | 27.76 | 791 | 1305 | 0.6058 | 0.8275 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 22.39 | 27.76 | 17 | 1305 | 0.0130 | -0.0845 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 22.39 | 27.76 | 865 | 1305 | 0.6625 | 0.8571 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 24.09 | 27.76 | 9 | 1461 | 0.0062 | -0.1788 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 24.09 | 27.76 | 724 | 1461 | 0.4953 | 0.7688 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 24.09 | 27.76 | 16 | 1461 | 0.0109 | -0.0919 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 24.09 | 27.76 | 907 | 1461 | 0.6205 | 0.8399 | MN20160318_Q01 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 25.79 | 27.76 | 9 | 1605 | 0.0056 | -0.1750 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 25.79 | 27.76 | 698 | 1605 | 0.4349 | 0.7348 | MN20160318_Q01 | H15 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 25.79 | 27.76 | 18 | 1605 | 0.0112 | -0.0713 | MN20160318_Q01 | I20 |